2007-02-14-世界卫生组织-10_million_treatments_supplied_in_6_years_16页_7mb

GDF Achievements Summary

Acknowledgements

• GDF expresses gratitude to Stop TB Partnership members, donors, and partners for their support in its establishment and success.
• Key individuals, committees, and organizations involved in setting up GDF and driving its progress are acknowledged.

Executive Summary

• The Global Drug Facility (GDF), under the Stop TB Partnership, has provided 10 million TB treatments in six years (2001-2007).
• Key achievements include ensuring drug supply to 78 countries, improving health systems, responding to emergencies, leveraging donor funds efficiently, and promoting high-quality treatment standards.

Key Achievements

1. Saving Millions of Lives

• Provided 10 million anti-TB treatments in its first six years.
• Focuses on uninterrupted supply of high-quality drugs to 78 countries since 2001.
• Prioritizes countries with low GNI per capita (< $3000), with priority < $1000.
• Notable impact in regions like the WHO African Region (36 countries) and Eastern Mediterranean (10 countries).

2. Building Health System Capacity

• Trained over 200 missions and workshops on drug management and procurement.
• Supported countries by providing free drugs, conditional on maintaining or increasing national budgets.
• Facilitated political commitment and helped gain long-term funding through bilateral and intergovernmental donors.

3. Responding to Urgent Drug Needs

• Responded to emergencies (e.g., earthquake in Pakistan) by providing emergency drug shipments.
• Addressed regional challenges like famines, conflicts, and infrastructure failures.
• Collaborated closely with in-country stakeholders and international partners for sustainable solutions.

4. Putting Resources into Action

• Secured $128 million from donors between 2001 and 2006, resulting in 10 million treatments.
• Achieved low drug prices through centralized, pooled procurement and competitive bidding.
• Emphasized efficiency and transparency, with over 80% of funds directly reinvested in drug procurement.
• GDF reduced drug costs by up to 87% in some countries compared to pre-2005 prices.

5. Promoting High-Quality Standards

• Ensured all drugs are prequalified or approved by WHO.
• Promoted standardized treatment regimens (DOTS) and fixed-dose combinations.
• Supported the development of high-quality treatments for multidrug-resistant tuberculosis (MDR-TB).
• Collaborated with industries to improve drug quality and packaging.

Operational Model

• GDF combines three services:
  1. Grant Service: Provides free first-line drugs to low-income countries.
  2. Direct Procurement: Supports governments and NGOs with procurement capacity.
  3. Technical Support: Offers monitoring, training, and mission services to strengthen country capacities.
• Functions include quality assurance, competitive bidding, and transparent operations.

About GDF

• Established in 2001, GDF supports the Stop TB Strategy by ensuring access to affordable, quality-assured anti-TB drugs.
• Hosted by the World Health Organization, GDF operates from Geneva, Switzerland.
• Website: www.stoptb.org/gdf, Email: gdf@who.int